Summary
Forty-two patients with active rheumatoid arthritis treated with hydroxychloroquine sulphate (400 mg day−1) for six months have been compared with patients treated with D-penicillamine (n=14), aurothiomalate (n=13), sulphasalazine (n=15) and chloroquine (n=17) to compare the changes in articular index, plasma viscosity and ERS. Results indicate that while articular index and plasma viscosity show significant improvement for all treatments, the ESR fails to improve during hydroxychloroquine therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Crockson, R.A., Crockson, P.A. Relationship of the erythrocyte sedimentation rate to viscosity and plasma proteins in rheumatoid arthritis. Ann Rheum Dis 1974, 33, 53–56.
Hutchinson, R.M., Eastham, R.D. A comparison of the erythrocyte sedimentation rate and plasma viscosity in detecting changes in plasma proteins. J Clin Pathol 1977, 30, 345–349.
Pickup, M.E., Dixon, J.S., Hallett, C., Bird, H.A., Wright, V. Plasma Viscosity — a new appraisal of its use as an index of disease activity in rheumatoid arthritis. Ann Rheum Dis 1981, 40, 272–275.
Larkin, J.G., Lowe, G.D.O., Sturrock, R.D., Forbes, C.D. The relationship of plasma and serum viscosity to disease activity and smoking habit in rheumatoid arthritis. Br J Rheumatol 1984, 23, 15–19.
Dixon, J.S. Relationship between plasma viscosity or ESR and the Ritchie articular index. Br J Rheumatol 1984, 23, 233–235.
Harreby, M., Danneskiold-Samsoe, B., Kjer, J., Lauritzen, M. Viscosity of plasma in patients with rheumatoid arthritis. Ann Rheum Dis 1987, 46, 601–604.
Dixon, J.S., Hayes, S., Constable, P.D.L., Bird, H.A. What are the “best” measurements for monitoring patients during short-term second-line therapy? Br J Rheumatol 1988, 27, 37–43.
Dixon, J.S., Pickup, M.E., Bird, H.A., Lee, M.R., Wright, V., Downie, W.W. Biochemical indices of response to hydroxychloroquine and sodium aurothiomalate in rheumatoid arthritis. Ann Rheum Dis 1981, 40, 480–488.
Ritchie, D.M., Boyle, J.A., McInnes, J.M., Jasani, M.K., Dalakos, T.G., Grieveson, P., Buchanan, W.W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968, 37, 393–406.
McConkey, B., Crockson, R.A., Crockson, A.P., Wilkinson, A.R. The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis. Q J Med 1973, 42 (168), 785–791.
Dixon, J.S. Biochemical and clinical changes in rheumatoid arthritis: their relation to the action of antirheumatoid drugs. Semin Arthritis Rheum 1982, 12, 191–207.
French, J.K., Hurst, N.P., ODonnell, M.L., Betts, W.H. Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy. Ann Rheum Dis 1987, 46, 42–45.
Lucherini, T., et al. Distribution of hydroxychloroquine in the blood of healthy subjects and subjects suffering from rheumatoid arthritis. Recenti Prog Med 1962, 33, 446–457.
Bird, H.A., Harkness, J., Wright, V. Some rheological properties of blood during anti-rheumatoid therapy. Pharmatherapeutica 1981, 3, 36–39.
Bjelle, A., Bjornham, A., Larsen, A., Mjorndal, T. Chloroquine in long-term treatment of rheumatoid arthritis. Clin Rheumatol 1983, 2, 393–399.
Bell, C.L. Hydroxychloroquine sulfate in rheumatoid arthritis: long-term response rate and predictive parameters. Am J Med 1983, 75, (1a), 46–51.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dixon, J.S., Greenwood, M. & Bird, H.A. How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?. Clin Rheumatol 7, 262–266 (1988). https://doi.org/10.1007/BF02204465
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02204465